Influence of the sample matrix on the stability of β-CTX at room temperature for 24 and 48 hours

Clinical Laboratory

Volumn 53, Issue 7-8, 2007, Pages 455-459

  Lippi, Giuseppe ^a   Brocco, Giorgio ^a   Salvagno, Gian Luca ^a   Montagana, Martina ^a   Guidi, Gian Cesare ^a   Schmidt Gayk, Heinrich ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b Limbach Laboratory   (Germany)

Author keywords

CrossLaps; CTX; C telopeptides of type I collagen; CTX; EDTA; Heparin plasma; Serum

Indexed keywords

BETA AMINO TERMINAL TELOPEPTIDE; COLLAGEN; EDETIC ACID; HEPARIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOANALYZER; CENTRIFUGATION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; OUTPATIENT; PROTEIN STABILITY; ROOM TEMPERATURE; STATISTICAL SIGNIFICANCE; STORAGE TEMPERATURE; THERMOSTABILITY;

COLLAGEN TYPE I; EDETIC ACID; HEPARIN; HUMANS; LITHIUM COMPOUNDS; PEPTIDE FRAGMENTS; PEPTIDES; POTASSIUM COMPOUNDS; PROTEIN DENATURATION; TEMPERATURE; TIME FACTORS;

EID: 34548255833     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Pagani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest 2005; 28:8-13
2. Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H. Markers of bone resorption - Measurement in serum, plasma or urine? Clin Lab 2003;49:203-7.
3. Meyer-Luerssen B, Traber L, Knorzer T, Schmidt-Gayk H. Bone resorption marker in pre- and postmenopausal females. Clin Lab 2000;46:295-90.
4. Fledelius C, Johnsen AH, Cloos PA, Bonde M, Qvist P. Characterization of urinary degradation products derived from type I collagen. Identification of a β-isomerized Asp-Gly sequence within the C-terminal telopeptide ({alpha}1) region. J Biol Chem 1997;272:9755-63.
5. Reichel H, Roth HJ, Schmidt-Gayk H. Evaluation of serum betacarboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients. Nephron Clin Pract 2004;98:c112-8.
6. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995;80:864-8.
7. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound cross-links excretion. J Bone Miner Res 1995;10:641-9.
8. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon it) laboratory testing. Clin Chem Lab Med 2006;44:358-65.
9. Wood WG. The preanalytical phase - Can the requirements of he DIN-EN-ISO 15189 be met practically for all laboratories? A review of the "German situation". Clin Lab 2005;51:665-71.
10. Guidi GC, Lippi G. Laboratory medicine in the 2000s: programmed death or rebirth? Clin Chem Lab Med 2006;44:913-7.
11. Lippi G, Brocco G, Dima F, Guidi GC. Measurement of β-CTX in lithium heparin plasma. Clin Lab (in press).
12. Dewitte K, Fierens C, Stockl D, Thienpont LM. Application of the Bland-Altman plot for interpretation of method-comparison studies: a critical investigation of its practice. Clin Chem 2002; 48:799-801.
13. Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H, et al. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem 2001;47:1410-4.
14. Qvist P, Munk M, Hoyle N, Christiansen C. Serum and plasma fragments of C-telopeptides of type I collagen (CTX) are stable during storage at low temperatures for 3 years. Clin Chim Acta 2004;350:167-73.
15. Roche Diagnostics, β-CTx on MODULAR ANALYTICS E170 [Package Insert] 2005 Roche Diagnostics.
16. Schmidt-Gayk H, Spanuth E, Kotting J, Bard R, Felsenberg D, Pfeilschifter J, Raue F, Roth HJ. Performance evaluation of automated assays for beta-CrossLaps, N-MID-osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med 2004;42:90-5.
17. Banfi G, Salvagno GL, Lippi G. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med, May 2007;45(5) (in press).